Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Free Report) – Roth Capital issued their Q3 2025 earnings per share estimates for Bioceres Crop Solutions in a report issued on Tuesday, July 2nd. Roth Capital analyst S. Fortune forecasts that the company will post earnings of $0.09 per share for the quarter. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.39 per share.
Separately, Roth Mkm initiated coverage on Bioceres Crop Solutions in a research report on Tuesday. They set a “buy” rating and a $15.00 target price on the stock.
Bioceres Crop Solutions Stock Up 0.7 %
BIOX opened at $11.08 on Wednesday. The business’s fifty day moving average is $11.33 and its two-hundred day moving average is $12.47. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.83 and a current ratio of 1.22. The company has a market cap of $695.79 million, a price-to-earnings ratio of 1,108.00 and a beta of 0.50. Bioceres Crop Solutions has a one year low of $10.10 and a one year high of $14.05.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its earnings results on Wednesday, May 29th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.02). The firm had revenue of $83.98 million for the quarter, compared to analysts’ expectations of $88.80 million. Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%.
Institutional Trading of Bioceres Crop Solutions
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Activest Wealth Management purchased a new stake in shares of Bioceres Crop Solutions in the first quarter valued at $30,000. Cape Investment Advisory Inc. purchased a new stake in shares of Bioceres Crop Solutions in the fourth quarter valued at $33,000. Wellington Management Group LLP lifted its position in shares of Bioceres Crop Solutions by 3.1% in the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after acquiring an additional 7,096 shares in the last quarter. Oppenheimer & Co. Inc. purchased a new stake in shares of Bioceres Crop Solutions in the first quarter valued at $139,000. Finally, Lazard Asset Management LLC purchased a new stake in shares of Bioceres Crop Solutions in the first quarter valued at $212,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Featured Articles
- Five stocks we like better than Bioceres Crop Solutions
- What is the Dogs of the Dow Strategy? Overview and Examples
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Consumer Staples Stocks, Explained
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.